How Long that a SARS‑CoV‑2 Variant Delay Impacts Required Period to Achieve Herd Immunity?

Beuy Joob, Viroj Wiwanitkit


Dear Editor, The coronavirus disease (COVID‑19) vaccine is the present preventive tool for COVID‑19 containment. Mass immunization is required for achieving herd immunity. If herd immunity is reached, a successful COVID‑19 containment is expected.[1,2] In general, the targeted population size that herd immunity will achieve is mainly based on the basic reproduction number and is generally estimated as 75%.[1,2] Regarding the required period to achieve the impact of herd immunity depends on many facts including the targeted population size (unit: %), base local infection prevalence (unit: %), vaccination rate (unit: %), efficacy of vaccine (unit: %), and monthly infection rate (unit: %).


COVID‑19; Herd Immunity; SARS‑CoV‑2; Vaccine


Randolph HE, Barreiro LB. Herd immunity: Understanding

COVID‑19. Immunity 2020;52:737‑41.

Frederiksen LSF, Zhang Y, Foged C, Thakur A. The long

road toward COVID‑19 herd immunity: Vaccine platform

technologies and mass immunization strategies. Front Immunol


Lippi G, Henry BM. How will emerging SARS‑CoV‑2 variants

impact herd immunity? Ann Transl Med 2021;9:585.